✦ LIBER ✦

Multicenter, randomized trials in 673 comparing the combination of edatrexate, mitomycin, and vinblastine (EMV) with mitomycin and vinblastine (MV) in patients with stage III and IV non-small cell lung cancer

Book ID: 122386114
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 145 KB
Volume: 11
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(94)94228-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin versus carboplatin in combinat

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial

✍ Paccagnella, Adriano; Favaretto, A.; Oniga, F.; Barbieri, F.; Ceresoli, G.; Torr 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Combination chemotherapy with mitomycin-

Combination chemotherapy with mitomycin-C, cisplatin, and vinblastine in the treatment of non-small-cell lung cancer

✍ Niell, Harvey B. ;Griffin, John P. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

The drug combination of mitomycin-C, cisplatin, and vinblastine was administered to 30 patients with stage III non-small-cell lung cancer. All patients had a performance status of 50% or greater, had evaluable disease, and had not received previous chemotherapy. The overall response rate was 37% wit

The combination of mitomycin, vinblastin

The combination of mitomycin, vinblastine and cisplatin is active in the palliation of stage IIIB-IV non-small-cell lung cancer

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Combination chemotherapy with mitomycin

Combination chemotherapy with mitomycin C, methotrexate, cisplatin, and vinblastine in the treatment of non-small cell lung cancer

✍ Harvey B. Niell; John P. Griffin; William H. West; Charles L. Neely 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB 👁 2 views

Phase III randomized trial comparing mod

Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer

✍ Sculier, J-P. 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 97 KB

Symptomatic, stage IV, non-small-cell lu

Symptomatic, stage IV, non-small-cell lung cancer (NSCLC): response, toxicity, performance status change and symptom relief in patients treated with cisplatin, vinblastine and mitomycin-C

✍ Diego Tummarello, Francesco Graziano… 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 558 KB